Table of Content

1 Study Coverage
1.1 Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.3 Market by Application
1.3.1 Global Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peptides Sales Estimates and Forecasts 2018-2029
2.2 Global Peptides Revenue by Region
2.2.1 Global Peptides Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Peptides Revenue by Region (2018-2024)
2.2.3 Global Peptides Revenue by Region (2024-2029)
2.2.4 Global Peptides Revenue Market Share by Region (2018-2029)
2.3 Global Peptides Sales Estimates and Forecasts 2018-2029
2.4 Global Peptides Sales by Region
2.4.1 Global Peptides Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Peptides Sales by Region (2018-2024)
2.4.3 Global Peptides Sales by Region (2024-2029)
2.4.4 Global Peptides Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Peptides Sales by Manufacturers
3.1.1 Global Peptides Sales by Manufacturers (2018-2024)
3.1.2 Global Peptides Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptides in 2022
3.2 Global Peptides Revenue by Manufacturers
3.2.1 Global Peptides Revenue by Manufacturers (2018-2024)
3.2.2 Global Peptides Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Peptides Revenue in 2022
3.3 Global Key Players of Peptides, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Peptides Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peptides, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peptides, Product Offered and Application
3.8 Global Key Manufacturers of Peptides, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peptides Sales by Type
4.1.1 Global Peptides Historical Sales by Type (2018-2024)
4.1.2 Global Peptides Forecasted Sales by Type (2024-2029)
4.1.3 Global Peptides Sales Market Share by Type (2018-2029)
4.2 Global Peptides Revenue by Type
4.2.1 Global Peptides Historical Revenue by Type (2018-2024)
4.2.2 Global Peptides Forecasted Revenue by Type (2024-2029)
4.2.3 Global Peptides Revenue Market Share by Type (2018-2029)
4.3 Global Peptides Price by Type
4.3.1 Global Peptides Price by Type (2018-2024)
4.3.2 Global Peptides Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Peptides Sales by Application
5.1.1 Global Peptides Historical Sales by Application (2018-2024)
5.1.2 Global Peptides Forecasted Sales by Application (2024-2029)
5.1.3 Global Peptides Sales Market Share by Application (2018-2029)
5.2 Global Peptides Revenue by Application
5.2.1 Global Peptides Historical Revenue by Application (2018-2024)
5.2.2 Global Peptides Forecasted Revenue by Application (2024-2029)
5.2.3 Global Peptides Revenue Market Share by Application (2018-2029)
5.3 Global Peptides Price by Application
5.3.1 Global Peptides Price by Application (2018-2024)
5.3.2 Global Peptides Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Peptides Market Size by Type
6.1.1 US & Canada Peptides Sales by Type (2018-2029)
6.1.2 US & Canada Peptides Revenue by Type (2018-2029)
6.2 US & Canada Peptides Market Size by Application
6.2.1 US & Canada Peptides Sales by Application (2018-2029)
6.2.2 US & Canada Peptides Revenue by Application (2018-2029)
6.3 US & Canada Peptides Market Size by Country
6.3.1 US & Canada Peptides Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Peptides Sales by Country (2018-2029)
6.3.3 US & Canada Peptides Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Peptides Market Size by Type
7.1.1 Europe Peptides Sales by Type (2018-2029)
7.1.2 Europe Peptides Revenue by Type (2018-2029)
7.2 Europe Peptides Market Size by Application
7.2.1 Europe Peptides Sales by Application (2018-2029)
7.2.2 Europe Peptides Revenue by Application (2018-2029)
7.3 Europe Peptides Market Size by Country
7.3.1 Europe Peptides Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Peptides Sales by Country (2018-2029)
7.3.3 Europe Peptides Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Peptides Market Size
8.1.1 China Peptides Sales (2018-2029)
8.1.2 China Peptides Revenue (2018-2029)
8.2 China Peptides Market Size by Application
8.2.1 China Peptides Sales by Application (2018-2029)
8.2.2 China Peptides Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Peptides Market Size by Type
9.1.1 Asia Peptides Sales by Type (2018-2029)
9.1.2 Asia Peptides Revenue by Type (2018-2029)
9.2 Asia Peptides Market Size by Application
9.2.1 Asia Peptides Sales by Application (2018-2029)
9.2.2 Asia Peptides Revenue by Application (2018-2029)
9.3 Asia Peptides Sales by Region
9.3.1 Asia Peptides Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Peptides Revenue by Region (2018-2029)
9.3.3 Asia Peptides Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peptides Market Size by Type
10.1.1 Middle East, Africa and Latin America Peptides Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Peptides Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Peptides Market Size by Application
10.2.1 Middle East, Africa and Latin America Peptides Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Peptides Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Peptides Sales by Country
10.3.1 Middle East, Africa and Latin America Peptides Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Peptides Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Peptides Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Cipla Ltd.
11.1.1 Cipla Ltd. Company Information
11.1.2 Cipla Ltd. Overview
11.1.3 Cipla Ltd. Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Cipla Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cipla Ltd. Recent Developments
11.2 Emcure Pharmaceuticals Pvt. Ltd.
11.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Information
11.2.2 Emcure Pharmaceuticals Pvt. Ltd. Overview
11.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Emcure Pharmaceuticals Pvt. Ltd. Recent Developments
11.3 Gland Pharma Limited
11.3.1 Gland Pharma Limited Company Information
11.3.2 Gland Pharma Limited Overview
11.3.3 Gland Pharma Limited Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Gland Pharma Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gland Pharma Limited Recent Developments
11.4 Troikaa Pharmaceuticals Ltd.
11.4.1 Troikaa Pharmaceuticals Ltd. Company Information
11.4.2 Troikaa Pharmaceuticals Ltd. Overview
11.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Troikaa Pharmaceuticals Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Troikaa Pharmaceuticals Ltd. Recent Developments
11.5 Biological E Limited
11.5.1 Biological E Limited Company Information
11.5.2 Biological E Limited Overview
11.5.3 Biological E Limited Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Biological E Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biological E Limited Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bharat Biotech Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Biotech Recent Developments
11.7 Samarth Life Sciences Pvt. Ltd.
11.7.1 Samarth Life Sciences Pvt. Ltd. Company Information
11.7.2 Samarth Life Sciences Pvt. Ltd. Overview
11.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Samarth Life Sciences Pvt. Ltd. Recent Developments
11.8 VHB Life Sciences Limited
11.8.1 VHB Life Sciences Limited Company Information
11.8.2 VHB Life Sciences Limited Overview
11.8.3 VHB Life Sciences Limited Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 VHB Life Sciences Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 VHB Life Sciences Limited Recent Developments
11.9 Celon Laboratories Pvt. Ltd.
11.9.1 Celon Laboratories Pvt. Ltd. Company Information
11.9.2 Celon Laboratories Pvt. Ltd. Overview
11.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Celon Laboratories Pvt. Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Celon Laboratories Pvt. Ltd. Recent Developments
11.10 United Biotech(P) Limited
11.10.1 United Biotech(P) Limited Company Information
11.10.2 United Biotech(P) Limited Overview
11.10.3 United Biotech(P) Limited Peptides Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 United Biotech(P) Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 United Biotech(P) Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peptides Industry Chain Analysis
12.2 Peptides Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptides Production Mode & Process
12.4 Peptides Sales and Marketing
12.4.1 Peptides Sales Channels
12.4.2 Peptides Distributors
12.5 Peptides Customers
13 Market Dynamics
13.1 Peptides Industry Trends
13.2 Peptides Market Drivers
13.3 Peptides Market Challenges
13.4 Peptides Market Restraints
14 Key Findings in The Global Peptides Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Insulin
Table 3. Major Manufacturers of Teriparatide
Table 4. Major Manufacturers of Liraglutide
Table 5. Major Manufacturers of Leuprolide
Table 6. Global Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Peptides Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Peptides Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Peptides Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Peptides Revenue Market Share by Region (2018-2024)
Table 11. Global Peptides Revenue Market Share by Region (2024-2029)
Table 12. Global Peptides Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Peptides Sales by Region (2018-2024) & (K Pcs)
Table 14. Global Peptides Sales by Region (2024-2029) & (K Pcs)
Table 15. Global Peptides Sales Market Share by Region (2018-2024)
Table 16. Global Peptides Sales Market Share by Region (2024-2029)
Table 17. Global Peptides Sales by Manufacturers (2018-2024) & (K Pcs)
Table 18. Global Peptides Sales Share by Manufacturers (2018-2024)
Table 19. Global Peptides Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Peptides Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Peptides, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Peptides Price by Manufacturers 2018-2024 (USD/Pcs)
Table 23. Global Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptides as of 2022)
Table 25. Global Key Manufacturers of Peptides, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Peptides, Product Offered and Application
Table 27. Global Key Manufacturers of Peptides, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Peptides Sales by Type (2018-2024) & (K Pcs)
Table 30. Global Peptides Sales by Type (2024-2029) & (K Pcs)
Table 31. Global Peptides Sales Share by Type (2018-2024)
Table 32. Global Peptides Sales Share by Type (2024-2029)
Table 33. Global Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Peptides Revenue Share by Type (2018-2024)
Table 36. Global Peptides Revenue Share by Type (2024-2029)
Table 37. Peptides Price by Type (2018-2024) & (USD/Pcs)
Table 38. Global Peptides Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 39. Global Peptides Sales by Application (2018-2024) & (K Pcs)
Table 40. Global Peptides Sales by Application (2024-2029) & (K Pcs)
Table 41. Global Peptides Sales Share by Application (2018-2024)
Table 42. Global Peptides Sales Share by Application (2024-2029)
Table 43. Global Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Peptides Revenue Share by Application (2018-2024)
Table 46. Global Peptides Revenue Share by Application (2024-2029)
Table 47. Peptides Price by Application (2018-2024) & (USD/Pcs)
Table 48. Global Peptides Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 49. US & Canada Peptides Sales by Type (2018-2024) & (K Pcs)
Table 50. US & Canada Peptides Sales by Type (2024-2029) & (K Pcs)
Table 51. US & Canada Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Peptides Sales by Application (2018-2024) & (K Pcs)
Table 54. US & Canada Peptides Sales by Application (2024-2029) & (K Pcs)
Table 55. US & Canada Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Peptides Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Peptides Sales by Country (2018-2024) & (K Pcs)
Table 61. US & Canada Peptides Sales by Country (2024-2029) & (K Pcs)
Table 62. Europe Peptides Sales by Type (2018-2024) & (K Pcs)
Table 63. Europe Peptides Sales by Type (2024-2029) & (K Pcs)
Table 64. Europe Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Peptides Sales by Application (2018-2024) & (K Pcs)
Table 67. Europe Peptides Sales by Application (2024-2029) & (K Pcs)
Table 68. Europe Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Peptides Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Peptides Sales by Country (2018-2024) & (K Pcs)
Table 74. Europe Peptides Sales by Country (2024-2029) & (K Pcs)
Table 75. China Peptides Sales by Type (2018-2024) & (K Pcs)
Table 76. China Peptides Sales by Type (2024-2029) & (K Pcs)
Table 77. China Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Peptides Sales by Application (2018-2024) & (K Pcs)
Table 80. China Peptides Sales by Application (2024-2029) & (K Pcs)
Table 81. China Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Peptides Sales by Type (2018-2024) & (K Pcs)
Table 84. Asia Peptides Sales by Type (2024-2029) & (K Pcs)
Table 85. Asia Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Peptides Sales by Application (2018-2024) & (K Pcs)
Table 88. Asia Peptides Sales by Application (2024-2029) & (K Pcs)
Table 89. Asia Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Peptides Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Peptides Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Peptides Sales by Region (2018-2024) & (K Pcs)
Table 95. Asia Peptides Sales by Region (2024-2029) & (K Pcs)
Table 96. Middle East, Africa and Latin America Peptides Sales by Type (2018-2024) & (K Pcs)
Table 97. Middle East, Africa and Latin America Peptides Sales by Type (2024-2029) & (K Pcs)
Table 98. Middle East, Africa and Latin America Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Peptides Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Peptides Sales by Application (2018-2024) & (K Pcs)
Table 101. Middle East, Africa and Latin America Peptides Sales by Application (2024-2029) & (K Pcs)
Table 102. Middle East, Africa and Latin America Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Peptides Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Peptides Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Peptides Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Peptides Sales by Country (2018-2024) & (K Pcs)
Table 108. Middle East, Africa and Latin America Peptides Sales by Country (2024-2029) & (K Pcs)
Table 109. Cipla Ltd. Company Information
Table 110. Cipla Ltd. Description and Major Businesses
Table 111. Cipla Ltd. Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Cipla Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Cipla Ltd. Recent Developments
Table 114. Emcure Pharmaceuticals Pvt. Ltd. Company Information
Table 115. Emcure Pharmaceuticals Pvt. Ltd. Description and Major Businesses
Table 116. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Emcure Pharmaceuticals Pvt. Ltd. Recent Developments
Table 119. Gland Pharma Limited Company Information
Table 120. Gland Pharma Limited Description and Major Businesses
Table 121. Gland Pharma Limited Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Gland Pharma Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Gland Pharma Limited Recent Developments
Table 124. Troikaa Pharmaceuticals Ltd. Company Information
Table 125. Troikaa Pharmaceuticals Ltd. Description and Major Businesses
Table 126. Troikaa Pharmaceuticals Ltd. Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Troikaa Pharmaceuticals Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Troikaa Pharmaceuticals Ltd. Recent Developments
Table 129. Biological E Limited Company Information
Table 130. Biological E Limited Description and Major Businesses
Table 131. Biological E Limited Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Biological E Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Biological E Limited Recent Developments
Table 134. Bharat Biotech Company Information
Table 135. Bharat Biotech Description and Major Businesses
Table 136. Bharat Biotech Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Bharat Biotech Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Bharat Biotech Recent Developments
Table 139. Samarth Life Sciences Pvt. Ltd. Company Information
Table 140. Samarth Life Sciences Pvt. Ltd. Description and Major Businesses
Table 141. Samarth Life Sciences Pvt. Ltd. Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Samarth Life Sciences Pvt. Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Samarth Life Sciences Pvt. Ltd. Recent Developments
Table 144. VHB Life Sciences Limited Company Information
Table 145. VHB Life Sciences Limited Description and Major Businesses
Table 146. VHB Life Sciences Limited Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. VHB Life Sciences Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. VHB Life Sciences Limited Recent Developments
Table 149. Celon Laboratories Pvt. Ltd. Company Information
Table 150. Celon Laboratories Pvt. Ltd. Description and Major Businesses
Table 151. Celon Laboratories Pvt. Ltd. Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Celon Laboratories Pvt. Ltd. Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Celon Laboratories Pvt. Ltd. Recent Developments
Table 154. United Biotech(P) Limited Company Information
Table 155. United Biotech(P) Limited Description and Major Businesses
Table 156. United Biotech(P) Limited Peptides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. United Biotech(P) Limited Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. United Biotech(P) Limited Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Peptides Distributors List
Table 162. Peptides Customers List
Table 163. Peptides Market Trends
Table 164. Peptides Market Drivers
Table 165. Peptides Market Challenges
Table 166. Peptides Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptides Product Picture
Figure 2. Global Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Peptides Market Share by Type in 2022 & 2029
Figure 4. Insulin Product Picture
Figure 5. Teriparatide Product Picture
Figure 6. Liraglutide Product Picture
Figure 7. Leuprolide Product Picture
Figure 8. Global Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Peptides Market Share by Application in 2022 & 2029
Figure 10. Diabetes
Figure 11. Infectious Diseases
Figure 12. Cancer
Figure 13. Osteoporosis
Figure 14. Peptides Report Years Considered
Figure 15. Global Peptides Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Peptides Revenue 2018-2029 (US$ Million)
Figure 17. Global Peptides Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Peptides Revenue Market Share by Region (2018-2029)
Figure 19. Global Peptides Sales 2018-2029 ((K Pcs)
Figure 20. Global Peptides Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Peptides Sales YoY (2018-2029) & (K Pcs)
Figure 22. US & Canada Peptides Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Peptides Sales YoY (2018-2029) & (K Pcs)
Figure 24. Europe Peptides Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Peptides Sales YoY (2018-2029) & (K Pcs)
Figure 26. China Peptides Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Peptides Sales YoY (2018-2029) & (K Pcs)
Figure 28. Asia (excluding China) Peptides Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Peptides Sales YoY (2018-2029) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Peptides Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Peptides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Peptides in the World: Market Share by Peptides Revenue in 2022
Figure 33. Global Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Peptides Sales Market Share by Type (2018-2029)
Figure 35. Global Peptides Revenue Market Share by Type (2018-2029)
Figure 36. Global Peptides Sales Market Share by Application (2018-2029)
Figure 37. Global Peptides Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Peptides Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Peptides Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Peptides Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Peptides Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Peptides Revenue Share by Country (2018-2029)
Figure 43. US & Canada Peptides Sales Share by Country (2018-2029)
Figure 44. U.S. Peptides Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Peptides Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Peptides Sales Market Share by Type (2018-2029)
Figure 47. Europe Peptides Revenue Market Share by Type (2018-2029)
Figure 48. Europe Peptides Sales Market Share by Application (2018-2029)
Figure 49. Europe Peptides Revenue Market Share by Application (2018-2029)
Figure 50. Europe Peptides Revenue Share by Country (2018-2029)
Figure 51. Europe Peptides Sales Share by Country (2018-2029)
Figure 52. Germany Peptides Revenue (2018-2029) & (US$ Million)
Figure 53. France Peptides Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Peptides Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Peptides Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Peptides Revenue (2018-2029) & (US$ Million)
Figure 57. China Peptides Sales Market Share by Type (2018-2029)
Figure 58. China Peptides Revenue Market Share by Type (2018-2029)
Figure 59. China Peptides Sales Market Share by Application (2018-2029)
Figure 60. China Peptides Revenue Market Share by Application (2018-2029)
Figure 61. Asia Peptides Sales Market Share by Type (2018-2029)
Figure 62. Asia Peptides Revenue Market Share by Type (2018-2029)
Figure 63. Asia Peptides Sales Market Share by Application (2018-2029)
Figure 64. Asia Peptides Revenue Market Share by Application (2018-2029)
Figure 65. Asia Peptides Revenue Share by Region (2018-2029)
Figure 66. Asia Peptides Sales Share by Region (2018-2029)
Figure 67. Japan Peptides Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Peptides Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Peptides Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Peptides Revenue (2018-2029) & (US$ Million)
Figure 71. India Peptides Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Peptides Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Peptides Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Peptides Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Peptides Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Peptides Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Peptides Sales Share by Country (2018-2029)
Figure 78. Brazil Peptides Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Peptides Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Peptides Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Peptides Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Peptides Revenue (2018-2029) & (US$ Million)
Figure 83. Peptides Value Chain
Figure 84. Peptides Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed